Confusion reigns as industry resists and challenges CMC labelling decision
This article was originally published in Clinica
Executive Summary
The medtech labelling decision made by the Central Management Committee, the year-old committee comprising competent authority representatives, has angered the medtech industry and led to questions over the legitimacy not only of this decision, but of all judgements made by this group.